Literature DB >> 1102986

Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).

E Genton, M Gent, J Hirsh, L A Harker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1102986     DOI: 10.1056/NEJM197512182932506

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.

Authors:  Entela Nuri; Mara Taraborelli; Laura Andreoli; Marta Tonello; Maria Gerosa; Antonia Calligaro; Lorenza Maria Argolini; Rajesh Kumar; Vittorio Pengo; Pier Luigi Meroni; Amelia Ruffatti; Angela Tincani
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

2.  Effects of aspirin and dextran on patency of bovine heterografts in the venous system.

Authors:  J J Ricotta; G J Collins; N M Rich
Journal:  Ann Surg       Date:  1979-01       Impact factor: 12.969

3.  Quantification of the morphological reaction of platelets to aggregating agents and of its reversal by aggregation inhibitors.

Authors:  G V Born; R Dearnley; J G Foulks; D E Sharp
Journal:  J Physiol       Date:  1978-07       Impact factor: 5.182

4.  Role of platelets in hemostasis and thrombosis.

Authors:  R Rodvien; C H Mielke
Journal:  West J Med       Date:  1976-09

5.  Dose-dependent inhibition of experimental arterial thrombosis by carbenicillin and ticarcillin.

Authors:  B T Lyman; G J Johnson; J G White
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

6.  Platelet consumption by arterial prostheses: the effects of endothelialization and pharmacologic inhibition of platelet function.

Authors:  L A Harker; S J Slichter; L R Sauvage
Journal:  Ann Surg       Date:  1977-11       Impact factor: 12.969

7.  Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?

Authors:  Christian A Devaux; Laurence Camoin-Jau; Jean-Louis Mege; Didier Raoult
Journal:  J Microbiol Immunol Infect       Date:  2021-01-05       Impact factor: 4.399

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.